U.S. Healthcare Services Stock News

In early March 2026, Abercrombie & Fitch Co. reported past fourth-quarter and full-year 2025 results with record sales of US$1,669.8 million and US$5,266.29 million respectively, even as net income eased to US$172.13 million for the quarter and US$506.92 million for the year, alongside ongoing share repurchases and new store expansion plans. The company coupled this performance with 2026 guidance targeting low single-digit net sales growth, double-digit operating margins of about 12.0% to...

Norwegian Cruise Line Holdings (NYSE:NCLH) has introduced its next-generation ship, Norwegian Luna, expanding its fleet with new onboard experiences and itineraries. The ship features updated entertainment, dining concepts, and family-focused amenities, along with itineraries that highlight destinations such as Great Stirrup Cay. This launch reflects a significant product refresh aimed at broadening the guest base, including multi generational families. Norwegian Cruise Line Holdings,...

If you are wondering whether Pulse Biosciences at around US$21.57 offers good value or is running ahead of itself, you are not alone. The stock has seen mixed recent moves, with an 18.9% return over the last 7 days, a 14.6% decline over the past 30 days, a 61.1% return year to date and a 27.6% return over the past year, while the 3 year return is very large and the 5 year return sits at an 8.5% decline. These moves have come against a backdrop of ongoing attention on Pulse Biosciences and...

If you are wondering whether Organon is simply beaten down or genuinely cheap, this article will walk through what the current share price might be implying about the company. The stock last closed at US$6.35, with returns of a 3.2% decline over 7 days, a 17.4% decline over 30 days, a 12.3% decline year to date and a 58.1% decline over the past year. This naturally raises questions about how the market is thinking about its risk and potential. Recent coverage around Organon has focused on...

Eastman Chemical (NYSE:EMN) has rolled out a new 2026 self help plan focused on deeper cost reductions and operational efficiency. The plan also targets expanded capital returns, signaling an intention to keep shareholder payouts in focus alongside internal improvements. Management is positioning the initiative as a material shift in how the company runs its business and allocates cash over the next few years. Eastman Chemical is launching this plan at a time when the stock has faced mixed...

If you are wondering whether Royal Caribbean Cruises at around US$272.54 still offers value or has already run too far, you are not alone. Many investors are now asking what a fair price for the stock really looks like. The share price has seen a 30.4% return over the past year and a very large return over three years, even as the stock has pulled back with a 2.0% decline over the last week, an 18.3% decline over the last month, and a 3.8% decline year to date. Recent headlines around Royal...

Quantum Computing stock snapshot after recent moves Quantum Computing (QUBT) has been drawing fresh attention after recent price volatility, with the shares around $7.30 and returns over the month and past 3 months showing double digit declines. See our latest analysis for Quantum Computing. The recent 1 day, 7 day and 30 day share price returns all show declines, and the 90 day share price return of a 39.4% fall contrasts with a very large 3 year total shareholder return. This suggests...

Matador Resources (MTDR) is back on investors’ radar after BMO Capital reaffirmed its positive view on the stock, citing core acreage quality, operational execution, production trends, and recent balance sheet moves. See our latest analysis for Matador Resources. The 1-month share price return of 17.77% and 90-day share price return of 29.11% suggest momentum has been building. The 5-year total shareholder return of 152.21% points to meaningful longer term value creation for investors who...

If you are wondering whether Himax Technologies at around US$9.84 still offers value or if the easy gains are gone, this article unpacks what the current price might be implying. The stock has posted returns of 33.0% over the last 7 days, 19.3% over 30 days, 15.4% year to date and 14.9% over 1 year, with a 3 year return of 46.0% and 5 year return of 1.7% that give important context for any valuation discussion. Recent coverage has focused on Himax's role as a semiconductor player in display...

Dividend affirmation and smoke free momentum draw attention Philip Morris International (PM) is back in focus after the board affirmed a regular quarterly dividend of $1.47 per share, alongside recent 2025 results that highlighted expanding smoke free product contributions. See our latest analysis for Philip Morris International. PM’s recent 1-day share price return of 1.55% and 7-day return of 2.75% sit against a 30-day share price return decline of 6.23%, while a 1-year total shareholder...

Why Paychex is on investors’ radar now Paychex (PAYX) has drawn renewed attention after recent share performance, with the stock roughly flat over the past month but showing a decline over the past 3 months and year. Against that backdrop, investors are reassessing how the company’s current valuation lines up with its earnings profile, income growth and position in the human capital management and payroll services market. See our latest analysis for Paychex. Recent trading has been choppy,...

Why TransUnion Is Back on Investors’ Radar TransUnion (TRU) has drawn fresh attention after a recent swing in its share performance, with the stock showing a 0.5% gain over the past day but a 9.6% decline over the past week. This short term volatility comes against a backdrop of mixed returns, including a 2.5% decline over the past month and a 17.4% decline over the past 3 months. This may prompt investors to reassess the company’s fundamentals. See our latest analysis for TransUnion. At...

SentinelOne (S) just posted its FY 2026 fourth quarter numbers with revenue of US$271.2 million and a basic EPS loss of US$0.33, alongside trailing twelve month revenue of US$1.0 billion and a basic EPS loss of US$1.37. The company has seen revenue move from US$225.5 million in FY 2025 Q4 to US$271.2 million in FY 2026 Q4, while quarterly basic EPS losses ranged between US$0.18 and US$0.63 over the past year. This sets the stage for investors to weigh solid top line scale against ongoing...

If you are wondering whether Pinterest is starting to look like value or still a falling knife, you are not alone. A closer look at what the current price implies can help you frame that question. The stock last closed at US$18.18, and recent returns have been weak, with a 9.1% decline over the past week, 4.8% over the last month, and a 31.6% drop year to date, while the 1 year and 5 year returns stand at 43.1% and 75.1% declines respectively. Recent coverage has focused on Pinterest as an...

If you are wondering whether Hartford Insurance Group's current share price still reflects good value, this article walks through what the numbers actually say rather than relying on headlines or hype. The stock last closed at US$132.93, with a 4.5% decline over the past week and a 6.4% decline over the past month, while the 1 year return stands at 13.7% and the 3 and 5 year returns are 114.1% and 117.3% respectively. Recent coverage around Hartford Insurance Group has focused on the company...

In early March 2026, Eli Lilly announced a US$3.00 billion, decade-long expansion in China centered on local production and supply for its oral obesity pill orforglipron, while simultaneously rolling out its new Employer Connect platform and Zepbound KwikPen to broaden access to obesity treatments in the U.S. Together, this China build-out and employer-focused access model underscore how Lilly is trying to anchor obesity care across both global manufacturing and U.S. benefits design. We’ll...

Via Transportation (NYSE:VIA) reports material improvements in city transit performance in the City of Mobile, including better reliability and staffing outcomes without additional budget. The company expands its work with Transport for West Midlands in the UK, adding Citymapper integration to support future regional transit planning. These developments highlight Via’s growing role as a partner for large scale public transit transformation across multiple geographies. Via Transportation,...

California has introduced new driving laws affecting ignition interlock devices, penalties for intoxication related vehicular manslaughter, and rules for autonomous vehicles and electric motorcycles. Mercury General (NYSE:MCY), through its Mercury Insurance brand, has highlighted these legal updates for policyholders and investors. The company views the changes as relevant for risk assessment, claims patterns, and driver behavior in its core California market. For Mercury General, which...

FedEx (NYSE:FDX) has rolled out a reusable, collapsible packaging system aimed at cutting waste and improving logistics efficiency. The company plans to spin off FedEx Freight, reshaping its business structure and separating the less than truckload operations from its core express and ground services. FedEx has announced new AI deployments across its network, focused on routing, capacity planning and operational decision support. FedEx has surpassed UPS in market capitalization for the first...

What Oklo’s Recent Share Performance Tells You Oklo (OKLO) has drawn fresh attention after a mixed stretch in the stock, with a 1 day decline of 2.0% contrasting with a gain over the past week, as well as weaker performance over the past month and past 3 months. See our latest analysis for Oklo. At a latest share price of $58.37, Oklo’s recent 1 day and 1 month share price declines sit alongside a weaker year to date share price return. However, the 1 year and 3 year total shareholder returns...

MicroVision, Inc. has reported its full-year 2025 results, with sales of US$1.21 million compared to US$4.70 million in 2024 and a net loss of US$94.98 million versus US$96.92 million, while basic loss per share from continuing operations narrowed to US$0.35 from US$0.46. The combination of falling revenue and a slightly smaller loss highlights the company’s challenge of scaling its business while still tightly managing costs. With sales declining year over year but net loss narrowing, we’ll...

If you are wondering whether Ormat Technologies' current share price lines up with its underlying value, this article will walk you through the numbers in a straightforward way. The stock closed at US$110.38, with returns of 1.4% over 7 days, a 10.4% decline over 30 days, a 2.9% decline year to date, and a 54.4% return over 1 year, alongside 3 year and 5 year returns of 39.8% and 49.7% respectively. Recent coverage has focused on Ormat Technologies as a long standing player in the US...

If you are wondering whether Delta Air Lines is priced attractively right now, this article walks through what the current share price might imply about its underlying value. The stock last closed at US$58.78, with a 7 day return of 0.4% decline, a 30 day return of 17.7% decline, a year to date return of 14.9% decline, a 1 year return of 27.3%, and a 3 year return of 83.8%. Recent coverage around Delta has focused on how investors are reassessing major US airlines as a group, including...

Ardelyx recently reported the peer-reviewed publication of pooled clinical data showing its IBSRELA (tenapanor) therapy delivered earlier and sustained symptom relief in adults with IBS-C, with no new safety concerns identified. The analysis offers clinicians practical guidance on treatment duration and symptom timelines, potentially influencing how IBSRELA is positioned and used in everyday care. We’ll now examine how this new evidence of earlier and sustained IBS-C symptom relief could...